Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

1.703 +0.123 (+7.78%)
Streaming Delayed Price Updated: 12:46 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,119,052
Open 1.590
Bid (Size) 1.700 (337)
Ask (Size) 1.710 (356)
Prev. Close 1.580
Today's Range 1.570 - 1.720
52wk Range 1.120 - 4.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
US Stocks Turn Higher; ISM Manufacturing PMI Drops In May
U.S. stocks turned higher midway through trading, with Nasdaq gaining around 100 points on Thursday. The Dow traded up 0.27% to 32,996.06 while the NASDAQ rose 0.76% to 13,034.08. The S&P 500, also... 
Via Benzinga
TheStreetReports: AI Biomedical Companies Disrupting Healthcare: INBS, DNA, IBRX, CDIO
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+7.78%
+7.78%
1 Month
+44.32%
+44.32%
3 Month
+21.64%
+21.64%
6 Month
-14.42%
-14.42%
1 Year
-44.71%
-44.71%

More News

Read More
Why Shares Of Ginkgo Bioworks (DNA) Are Up Today
Via Benzinga
3 Reasons Why Cathie Wood Is Buying Ginkgo Bioworks Stock Hand Over Fist
Via The Motley Fool
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
Via InvestorPlace
Ginkgo Bioworks Holdings: Q1 Earnings Insights
Via Benzinga
Earnings Preview: Ginkgo Bioworks Holdings
Via Benzinga
3 Key Biotech Trends for 2023 And Beyond
Via The Motley Fool
Ginkgo Bioworks Q1 Sales Beat Expectations, But Analyst Downgrades Stock On Guidance Concerns
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
Disney, Sonos, Desktop Metal And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
After-Hours Action: Why Ginkgo Bioworks Stock Is Sliding
Via Benzinga
DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates
Via InvestorPlace
Down 76% From Its High, Can Ginkgo Bioworks Stock Turn Things Around?
Via The Motley Fool
7 Best Cathie Wood Stocks for Your May 2023 Buy List
Via InvestorPlace
Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth Stock
Via The Motley Fool
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Via Talk Markets
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Investor Notice: Investigation over Potential Wrongdoing
Via SBWire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Cathie Wood Bets Big On Roblox With $19.5M Purchase — Also Loads Up On This Biotech Stock
Via Benzinga
5 Penny Stocks With Explosive 5X Potential
Via InvestorPlace
3 Growth Stocks to Buy for 100% Returns
Via InvestorPlace
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
Via Benzinga
This Growth Stock Is Down 63% in 1 Year. Here's Why You Should Buy the Dip and Hold It for 5 Years
Via The Motley Fool
Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.